{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:54:30Z","timestamp":1791057270710,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.oftale.2026.502667","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:22:00Z","timestamp":1790004120000},"page":"502667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delayed inflammatory chorioretinopathy with VKH-like features and bilateral choroidal neovascularization after nivolumab\u2013ipilimumab dual checkpoint blockade for metastatic melanoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7901-686X","authenticated-orcid":false,"given":"T.","family":"Stalmashka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Mart\u00ednez Sobrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pastor-Idoate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2026.502667_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12348-022-00321-2","article-title":"Ocular adverse events associated with immune checkpoint inhibitors, a scoping review","volume":"13","author":"Martens","year":"2023","journal-title":"J Ophthal Inflamm Infect"},{"key":"10.1016\/j.oftale.2026.502667_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ICB.0000000000000882","article-title":"Choroidal neovascularization and chorioretinal atrophy in a patient with melanoma associated retinopathy after ipilimumab\/nivolumab combination therapy","volume":"15","author":"Elwood","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oftale.2026.502667_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112547","article-title":"Emerging ocular side effects of immune checkpoint inhibitors: a comprehensive review","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines."},{"key":"10.1016\/j.oftale.2026.502667_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/01676830.2020.1867192","article-title":"Ophthalmic complications of immune checkpoint inhibitors","volume":"41","author":"Wladis","year":"2021","journal-title":"Orbit"},{"key":"10.1016\/j.oftale.2026.502667_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/WNO.0000000000001148","article-title":"Neuro-ophthalmic complications in patients treated with CTLA-4 and PD-1\/PD-L1 checkpoint blockade","volume":"41","author":"Sun","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.oftale.2026.502667_bib0030","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41433-025-03720-6","article-title":"Vogt-Koyanagi-Harada-like disease secondary to anticancer treatment: a multicentre case series","volume":"39","author":"Urzua","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oftale.2026.502667_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajo.2026.05.046","article-title":"Immune checkpoint inhibitor-associated uveitis: insights from comparative analyses across malignancies and drug classes","volume":"289","author":"Bellanda","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502667_bib0040","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamaophthalmol.2016.2944","article-title":"Chorioretinal lesions in a case of melanoma-associated retinopathy treated with pembrolizumab","volume":"134","author":"Roberts","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oftale.2026.502667_bib0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/15569527.2013.781618","article-title":"Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma","volume":"32","author":"Modjtahedi","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.oftale.2026.502667_bib0050","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00262-020-02635-3","article-title":"Factors associated with ocular adverse event after immune checkpoint inhibitor treatment","volume":"69","author":"Kim","year":"2020","journal-title":"Cancer Immunol Immunother"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426002161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426002161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:38:54Z","timestamp":1791056334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579426002161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S2173579426002161"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502667","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed inflammatory chorioretinopathy with VKH-like features and bilateral choroidal neovascularization after nivolumab\u2013ipilimumab dual checkpoint blockade for metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2026.502667","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Oftalmolog\u00eda. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502667"}}